Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Needle-Free Drug Injection Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Needle-Free Drug Injection Systems is estimated at US$15.9 Billion in 2023 and is projected to reach US$29.9 Billion by 2030, growing at a CAGR of 9.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The growth of the needle-free drug injection system market is driven by multiple factors, including continuous technological innovations that enhance drug delivery mechanisms and device ergonomics. These advancements make the systems more efficient and user-friendly, fostering broader adoption. Stricter regulatory and safety standards aimed at reducing needlestick injuries and related liabilities also promote the shift towards needle-free systems. Healthcare worker advocacy and patient demand for less invasive treatment options further influence this trend, especially among individuals with needle aversions.
Additionally, the integration of these systems with digital health records facilitates better patient data management, enhancing workflow efficiency. Needle-free systems are particularly cost-effective for mass immunization programs, providing quick and easy vaccine administration. Lastly, these systems align with environmental sustainability goals by reducing medical waste associated with disposable needles, highlighting their appeal in modern healthcare settings where technological efficiency, patient comfort, and environmental considerations are increasingly prioritized.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Needle-Free Drug Injection Systems Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Needle-Free Drug Injection Systems Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Jet Injectors Technology segment, which is expected to reach US$9.5 Billion by 2030 with a CAGR of a 9.5%. The Novel Needle-Free Technology segment is also set to grow at 8.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $4.2 Billion in 2023, and China, forecasted to grow at an impressive 12.5% CAGR to reach $6.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AKRA Dermojet, Crossject SA, D`Antonio Consultants International, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 278 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $15.9 Billion |
| Forecasted Market Value (USD) by 2030 | $29.9 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Needle-Free Drug Injection Systems - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Prevalence of Chronic Diseases Throws the Spotlight on Needle-Free Drug Injection Systems
- Growing Focus on Pain-Free Delivery Methods Spurs Growth
- Advancements in Biologics Propel Growth in Needle-Free Drug Delivery
- Increased Adoption of Home Healthcare Solutions Expands Addressable Market Opportunity
- Innovations in Jet Injection Technology Strengthen Business Case for Needle-Free Systems
- Growing Awareness of Needle Stick Injuries and Infections Sustains Growth
- Here's the Story on the Transition from Conventional to Needle-Free Systems
- Here's How New Formulations and Drugs Accelerate Demand for Needle-Free Technologies
- Cost-Effectiveness and Efficiency of Needle-Free Systems Propel Market Expansion
- Rising Use of Self-Administration Techniques Spurs Growth of Needle-Free Devices
- Technological Advancements and Integration with Smart Technologies Drive Adoption
- Expansion of Vaccination Programs Generates Demand for Needle-Free Solutions
- Focus on Reducing Medical Waste Expands Market for Needle-Free Drug Delivery
- Here's How Digital Health Trends Drive Adoption of Needle-Free Systems
- Patient-Centric Approaches Propel Growth in Needle-Free Drug Delivery Market
- Stringent Regulations on Conventional Needles Propel Shift to Needle-Free Technologies
- Increasing Geriatric Population Spurs Growth in Needle-Free Drug Injection Systems
- Here's the Story on the Evolution of Needle-Free Technology and its Market Impact
FOCUS ON SELECT PLAYERS (Total 52 Featured)
- AKRA Dermojet
- Crossject SA
- D`Antonio Consultants International, Inc.
- Medical International Technologies, Inc.
- National Medical Products, Inc.
- PharmaJet
- Zogenix, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/13yh58
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
